| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aphasia | 48 | 2023 | 119 | 17.310 |
Why?
|
| Epilepsy, Temporal Lobe | 56 | 2022 | 138 | 15.080 |
Why?
|
| Connectome | 35 | 2022 | 91 | 12.290 |
Why?
|
| Brain | 68 | 2022 | 2175 | 8.150 |
Why?
|
| White Matter | 23 | 2021 | 174 | 7.690 |
Why?
|
| Stroke | 61 | 2022 | 2161 | 6.830 |
Why?
|
| Temporal Lobe | 31 | 2021 | 125 | 6.510 |
Why?
|
| Magnetic Resonance Imaging | 119 | 2022 | 2222 | 6.400 |
Why?
|
| Diffusion Tensor Imaging | 37 | 2021 | 211 | 6.290 |
Why?
|
| Nerve Net | 25 | 2022 | 180 | 6.230 |
Why?
|
| Brain Mapping | 55 | 2022 | 531 | 6.180 |
Why?
|
| Speech | 23 | 2022 | 118 | 6.070 |
Why?
|
| Neural Pathways | 29 | 2022 | 323 | 5.270 |
Why?
|
| Language | 22 | 2023 | 120 | 5.030 |
Why?
|
| Drug Resistant Epilepsy | 11 | 2021 | 44 | 4.520 |
Why?
|
| Epilepsy | 18 | 2022 | 336 | 3.400 |
Why?
|
| Hippocampus | 29 | 2022 | 471 | 3.350 |
Why?
|
| Image Processing, Computer-Assisted | 37 | 2020 | 689 | 3.240 |
Why?
|
| Transcranial Direct Current Stimulation | 5 | 2022 | 111 | 2.760 |
Why?
|
| Middle Aged | 119 | 2022 | 21119 | 2.670 |
Why?
|
| Humans | 223 | 2023 | 68525 | 2.630 |
Why?
|
| Language Disorders | 8 | 2022 | 22 | 2.600 |
Why?
|
| Machine Learning | 6 | 2022 | 170 | 2.540 |
Why?
|
| Stroke Rehabilitation | 14 | 2023 | 334 | 2.430 |
Why?
|
| Adult | 123 | 2022 | 21375 | 2.430 |
Why?
|
| Electroencephalography | 24 | 2022 | 418 | 2.400 |
Why?
|
| Male | 146 | 2022 | 37281 | 2.320 |
Why?
|
| Female | 146 | 2022 | 38015 | 2.290 |
Why?
|
| Cerebral Cortex | 15 | 2021 | 415 | 2.210 |
Why?
|
| Epilepsies, Partial | 6 | 2021 | 24 | 2.130 |
Why?
|
| Functional Laterality | 23 | 2022 | 240 | 2.130 |
Why?
|
| Axons | 5 | 2021 | 139 | 2.090 |
Why?
|
| Comprehension | 10 | 2022 | 71 | 2.050 |
Why?
|
| Seizures | 10 | 2022 | 279 | 1.990 |
Why?
|
| Language Tests | 15 | 2022 | 36 | 1.910 |
Why?
|
| Speech Therapy | 6 | 2021 | 19 | 1.820 |
Why?
|
| Anterior Temporal Lobectomy | 5 | 2020 | 12 | 1.790 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 16 | 2021 | 239 | 1.790 |
Why?
|
| Aphasia, Broca | 7 | 2021 | 11 | 1.760 |
Why?
|
| Atrophy | 22 | 2022 | 112 | 1.670 |
Why?
|
| Frontal Lobe | 10 | 2019 | 156 | 1.600 |
Why?
|
| Cognition | 6 | 2020 | 512 | 1.520 |
Why?
|
| Aged | 58 | 2022 | 14842 | 1.490 |
Why?
|
| Neuroimaging | 10 | 2020 | 122 | 1.440 |
Why?
|
| Brain Injuries | 5 | 2021 | 268 | 1.400 |
Why?
|
| Amygdala | 7 | 2019 | 159 | 1.390 |
Why?
|
| Epilepsy, Generalized | 4 | 2022 | 15 | 1.340 |
Why?
|
| Speech Perception | 9 | 2021 | 261 | 1.300 |
Why?
|
| Recovery of Function | 11 | 2022 | 506 | 1.280 |
Why?
|
| Neuropsychological Tests | 21 | 2022 | 517 | 1.270 |
Why?
|
| Gray Matter | 5 | 2021 | 57 | 1.180 |
Why?
|
| Image Interpretation, Computer-Assisted | 8 | 2020 | 237 | 1.180 |
Why?
|
| Brain Ischemia | 8 | 2019 | 665 | 0.970 |
Why?
|
| Retrospective Studies | 24 | 2022 | 7264 | 0.960 |
Why?
|
| Intelligence | 5 | 2020 | 45 | 0.960 |
Why?
|
| Motor Cortex | 5 | 2020 | 158 | 0.930 |
Why?
|
| Anomia | 4 | 2020 | 9 | 0.890 |
Why?
|
| Models, Neurological | 5 | 2020 | 136 | 0.870 |
Why?
|
| Learning | 2 | 2022 | 186 | 0.840 |
Why?
|
| Neurosurgical Procedures | 3 | 2020 | 98 | 0.830 |
Why?
|
| Adolescent | 34 | 2022 | 8903 | 0.820 |
Why?
|
| Attention | 7 | 2022 | 225 | 0.790 |
Why?
|
| Pattern Recognition, Visual | 4 | 2019 | 69 | 0.790 |
Why?
|
| Parkinson Disease | 2 | 2022 | 272 | 0.770 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2019 | 124 | 0.760 |
Why?
|
| Human Development | 1 | 2020 | 6 | 0.760 |
Why?
|
| Ventral Thalamic Nuclei | 1 | 2019 | 4 | 0.720 |
Why?
|
| Limbic System | 6 | 2016 | 106 | 0.720 |
Why?
|
| Leukoencephalopathies | 1 | 2019 | 13 | 0.720 |
Why?
|
| Chronic Disease | 12 | 2021 | 1329 | 0.710 |
Why?
|
| Essential Tremor | 1 | 2019 | 8 | 0.710 |
Why?
|
| Cohort Studies | 10 | 2022 | 2356 | 0.710 |
Why?
|
| Nerve Fibers, Myelinated | 4 | 2014 | 49 | 0.710 |
Why?
|
| Cerebral Ventricles | 1 | 2019 | 36 | 0.710 |
Why?
|
| Treatment Outcome | 18 | 2022 | 7028 | 0.700 |
Why?
|
| Case-Control Studies | 15 | 2021 | 1548 | 0.700 |
Why?
|
| Memory Disorders | 4 | 2020 | 111 | 0.690 |
Why?
|
| Cerebellum | 2 | 2019 | 103 | 0.690 |
Why?
|
| Brain Diseases | 3 | 2019 | 78 | 0.680 |
Why?
|
| Thalamus | 4 | 2010 | 82 | 0.680 |
Why?
|
| Genotype | 4 | 2019 | 785 | 0.680 |
Why?
|
| Aphasia, Wernicke | 2 | 2022 | 3 | 0.670 |
Why?
|
| Young Adult | 23 | 2021 | 5708 | 0.660 |
Why?
|
| Fibroblast Growth Factors | 1 | 2018 | 51 | 0.650 |
Why?
|
| Occipital Lobe | 2 | 2017 | 18 | 0.640 |
Why?
|
| Semantics | 5 | 2022 | 37 | 0.640 |
Why?
|
| Dystonic Disorders | 2 | 2008 | 9 | 0.630 |
Why?
|
| Anisotropy | 6 | 2020 | 105 | 0.620 |
Why?
|
| Severity of Illness Index | 9 | 2020 | 1851 | 0.590 |
Why?
|
| Preoperative Care | 2 | 2016 | 275 | 0.580 |
Why?
|
| Leukoaraiosis | 3 | 2022 | 14 | 0.570 |
Why?
|
| Evoked Potentials | 5 | 2022 | 61 | 0.560 |
Why?
|
| Diagnosis, Computer-Assisted | 3 | 2018 | 75 | 0.560 |
Why?
|
| Photic Stimulation | 10 | 2021 | 229 | 0.560 |
Why?
|
| Entorhinal Cortex | 3 | 2007 | 11 | 0.550 |
Why?
|
| Deglutition Disorders | 4 | 2022 | 297 | 0.550 |
Why?
|
| Neuroanatomy | 1 | 2015 | 14 | 0.540 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 503 | 0.540 |
Why?
|
| Somatosensory Cortex | 1 | 2015 | 22 | 0.530 |
Why?
|
| Cognition Disorders | 4 | 2016 | 342 | 0.520 |
Why?
|
| Aged, 80 and over | 18 | 2022 | 4843 | 0.510 |
Why?
|
| Visual Perception | 4 | 2021 | 124 | 0.510 |
Why?
|
| Memory | 4 | 2019 | 214 | 0.490 |
Why?
|
| Cardiovascular Diseases | 2 | 2018 | 938 | 0.490 |
Why?
|
| Decision Making | 1 | 2017 | 410 | 0.490 |
Why?
|
| Prefrontal Cortex | 3 | 2022 | 639 | 0.480 |
Why?
|
| Upper Extremity | 6 | 2022 | 112 | 0.480 |
Why?
|
| Speech Production Measurement | 4 | 2019 | 14 | 0.480 |
Why?
|
| Cerebral Infarction | 1 | 2014 | 103 | 0.470 |
Why?
|
| Auditory Perception | 4 | 2022 | 89 | 0.450 |
Why?
|
| Schizophrenia | 2 | 2020 | 206 | 0.450 |
Why?
|
| Imaging, Three-Dimensional | 6 | 2011 | 333 | 0.430 |
Why?
|
| Apraxias | 2 | 2015 | 4 | 0.420 |
Why?
|
| Perceptual Disorders | 2 | 2022 | 23 | 0.420 |
Why?
|
| Acoustic Stimulation | 5 | 2021 | 206 | 0.410 |
Why?
|
| Support Vector Machine | 3 | 2021 | 15 | 0.400 |
Why?
|
| Aging | 3 | 2019 | 911 | 0.390 |
Why?
|
| Dominance, Cerebral | 5 | 2018 | 65 | 0.390 |
Why?
|
| Child, Preschool | 10 | 2020 | 3185 | 0.380 |
Why?
|
| Parietal Lobe | 7 | 2022 | 59 | 0.370 |
Why?
|
| Executive Function | 3 | 2016 | 106 | 0.370 |
Why?
|
| Feedback, Sensory | 2 | 2022 | 16 | 0.360 |
Why?
|
| Anticonvulsants | 3 | 2007 | 223 | 0.350 |
Why?
|
| Child | 15 | 2021 | 6400 | 0.350 |
Why?
|
| Infant | 6 | 2023 | 2891 | 0.350 |
Why?
|
| Neuronal Plasticity | 4 | 2022 | 274 | 0.340 |
Why?
|
| Broca Area | 2 | 2021 | 5 | 0.340 |
Why?
|
| Motor Disorders | 2 | 2020 | 4 | 0.340 |
Why?
|
| Psychomotor Performance | 6 | 2018 | 213 | 0.340 |
Why?
|
| Diagnostic Imaging | 3 | 2007 | 201 | 0.340 |
Why?
|
| Periaqueductal Gray | 1 | 2007 | 9 | 0.320 |
Why?
|
| Field Dependence-Independence | 1 | 2007 | 3 | 0.320 |
Why?
|
| Schizophrenic Psychology | 1 | 2007 | 53 | 0.310 |
Why?
|
| Follow-Up Studies | 7 | 2021 | 3256 | 0.310 |
Why?
|
| Organ Size | 4 | 2020 | 242 | 0.310 |
Why?
|
| Imitative Behavior | 2 | 2021 | 4 | 0.310 |
Why?
|
| Necrosis | 3 | 2018 | 239 | 0.310 |
Why?
|
| Transcranial Magnetic Stimulation | 3 | 2020 | 413 | 0.310 |
Why?
|
| Phonetics | 3 | 2022 | 42 | 0.300 |
Why?
|
| Cross-Sectional Studies | 10 | 2022 | 2264 | 0.300 |
Why?
|
| Autistic Disorder | 1 | 2008 | 77 | 0.300 |
Why?
|
| Language Therapy | 3 | 2021 | 9 | 0.300 |
Why?
|
| ROC Curve | 3 | 2020 | 392 | 0.290 |
Why?
|
| Choristoma | 1 | 2006 | 20 | 0.290 |
Why?
|
| Articulation Disorders | 1 | 2006 | 2 | 0.290 |
Why?
|
| Hematoma, Epidural, Cranial | 2 | 2003 | 5 | 0.290 |
Why?
|
| Automobile Driving | 1 | 2007 | 88 | 0.290 |
Why?
|
| Bayes Theorem | 3 | 2022 | 303 | 0.290 |
Why?
|
| Pyramidal Tracts | 3 | 2021 | 45 | 0.290 |
Why?
|
| Neurons | 1 | 2012 | 881 | 0.280 |
Why?
|
| Risk Factors | 7 | 2022 | 5719 | 0.280 |
Why?
|
| Cognitive Dysfunction | 2 | 2019 | 176 | 0.270 |
Why?
|
| Sclerosis | 5 | 2022 | 32 | 0.270 |
Why?
|
| Mathematical Computing | 1 | 2005 | 12 | 0.270 |
Why?
|
| Poisoning | 1 | 2005 | 21 | 0.260 |
Why?
|
| Models, Theoretical | 3 | 2021 | 384 | 0.260 |
Why?
|
| Psycholinguistics | 2 | 2021 | 10 | 0.250 |
Why?
|
| Scorpion Stings | 1 | 2004 | 8 | 0.250 |
Why?
|
| Seizures, Febrile | 1 | 2004 | 10 | 0.250 |
Why?
|
| Analysis of Variance | 7 | 2012 | 1039 | 0.240 |
Why?
|
| Computer Simulation | 4 | 2019 | 705 | 0.240 |
Why?
|
| Longitudinal Studies | 4 | 2021 | 1054 | 0.240 |
Why?
|
| Reproducibility of Results | 5 | 2022 | 2077 | 0.240 |
Why?
|
| Arachnoid Cysts | 2 | 2003 | 5 | 0.240 |
Why?
|
| Skull Fractures | 1 | 2003 | 17 | 0.240 |
Why?
|
| Age of Onset | 4 | 2014 | 188 | 0.230 |
Why?
|
| Reference Values | 4 | 2012 | 579 | 0.230 |
Why?
|
| Speech-Language Pathology | 2 | 2020 | 24 | 0.230 |
Why?
|
| Space Perception | 3 | 2022 | 44 | 0.220 |
Why?
|
| Language Development Disorders | 1 | 2022 | 9 | 0.220 |
Why?
|
| Artificial Intelligence | 2 | 2021 | 159 | 0.220 |
Why?
|
| Parahippocampal Gyrus | 2 | 2020 | 15 | 0.220 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2012 | 2323 | 0.210 |
Why?
|
| Pitch Perception | 1 | 2022 | 14 | 0.210 |
Why?
|
| Postoperative Complications | 2 | 2020 | 1615 | 0.210 |
Why?
|
| Algorithms | 5 | 2018 | 1194 | 0.200 |
Why?
|
| Mouth | 1 | 2021 | 64 | 0.200 |
Why?
|
| Registries | 1 | 2005 | 730 | 0.200 |
Why?
|
| Disease Progression | 6 | 2019 | 1037 | 0.200 |
Why?
|
| Nerve Fibers | 2 | 2019 | 77 | 0.200 |
Why?
|
| Stereotaxic Techniques | 2 | 2019 | 35 | 0.200 |
Why?
|
| Corpus Callosum | 1 | 2021 | 29 | 0.200 |
Why?
|
| Epileptic Syndromes | 1 | 2020 | 3 | 0.190 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2000 | 13 | 0.190 |
Why?
|
| Astrocytoma | 1 | 2000 | 30 | 0.190 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2022 | 86 | 0.190 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2021 | 81 | 0.190 |
Why?
|
| Cortical Excitability | 1 | 2020 | 7 | 0.190 |
Why?
|
| Linear Models | 3 | 2017 | 521 | 0.190 |
Why?
|
| Vocabulary | 1 | 2020 | 14 | 0.190 |
Why?
|
| Activities of Daily Living | 1 | 2022 | 319 | 0.190 |
Why?
|
| Neoplasms, Second Primary | 1 | 2000 | 61 | 0.180 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 1046 | 0.180 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2000 | 79 | 0.180 |
Why?
|
| Quality of Life | 3 | 2022 | 1515 | 0.180 |
Why?
|
| Drug Resistance | 3 | 2019 | 223 | 0.180 |
Why?
|
| Brain Neoplasms | 2 | 2004 | 371 | 0.180 |
Why?
|
| Serum Amyloid A Protein | 1 | 2019 | 33 | 0.180 |
Why?
|
| Pilonidal Sinus | 1 | 1999 | 1 | 0.180 |
Why?
|
| Dermoid Cyst | 1 | 1999 | 4 | 0.180 |
Why?
|
| Laser Therapy | 1 | 2019 | 54 | 0.180 |
Why?
|
| Regression Analysis | 4 | 2011 | 737 | 0.180 |
Why?
|
| Hypoalbuminemia | 1 | 2019 | 9 | 0.170 |
Why?
|
| Pharmacokinetics | 1 | 2019 | 14 | 0.170 |
Why?
|
| Inflammasomes | 1 | 2019 | 39 | 0.170 |
Why?
|
| Data Interpretation, Statistical | 4 | 2016 | 329 | 0.170 |
Why?
|
| Skull | 1 | 1999 | 63 | 0.170 |
Why?
|
| Cortical Synchronization | 1 | 2019 | 6 | 0.170 |
Why?
|
| Facial Recognition | 1 | 2019 | 13 | 0.170 |
Why?
|
| Vision Disorders | 1 | 2019 | 94 | 0.170 |
Why?
|
| Serum Albumin | 1 | 2019 | 104 | 0.170 |
Why?
|
| Central Nervous System Agents | 1 | 2019 | 37 | 0.170 |
Why?
|
| Sensorimotor Cortex | 1 | 2019 | 18 | 0.170 |
Why?
|
| Touch Perception | 1 | 2019 | 18 | 0.170 |
Why?
|
| Brain Waves | 1 | 2019 | 30 | 0.170 |
Why?
|
| Deep Brain Stimulation | 1 | 2019 | 71 | 0.170 |
Why?
|
| Neurotransmitter Agents | 1 | 2019 | 102 | 0.170 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2011 | 181 | 0.170 |
Why?
|
| Linguistics | 2 | 2023 | 10 | 0.170 |
Why?
|
| Valproic Acid | 1 | 2019 | 93 | 0.170 |
Why?
|
| Sample Size | 2 | 2017 | 79 | 0.170 |
Why?
|
| Vascular Stiffness | 1 | 2018 | 31 | 0.160 |
Why?
|
| Placebos | 1 | 2018 | 195 | 0.160 |
Why?
|
| Double-Blind Method | 2 | 2021 | 1737 | 0.160 |
Why?
|
| Eating | 1 | 2019 | 119 | 0.160 |
Why?
|
| Microglia | 1 | 2019 | 143 | 0.160 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2021 | 100 | 0.160 |
Why?
|
| Encephalocele | 1 | 2018 | 30 | 0.160 |
Why?
|
| Cell Count | 1 | 2018 | 248 | 0.160 |
Why?
|
| Task Performance and Analysis | 1 | 2019 | 150 | 0.160 |
Why?
|
| Inflammation Mediators | 1 | 2019 | 244 | 0.160 |
Why?
|
| Demography | 2 | 2022 | 279 | 0.160 |
Why?
|
| Pattern Recognition, Physiological | 1 | 2017 | 22 | 0.160 |
Why?
|
| Enteral Nutrition | 1 | 2019 | 157 | 0.150 |
Why?
|
| Walking Speed | 1 | 2017 | 31 | 0.150 |
Why?
|
| Predictive Value of Tests | 3 | 2017 | 1465 | 0.150 |
Why?
|
| Probability | 1 | 2017 | 244 | 0.150 |
Why?
|
| Prognosis | 4 | 2023 | 2093 | 0.150 |
Why?
|
| Electric Stimulation Therapy | 1 | 2019 | 147 | 0.150 |
Why?
|
| Vascular Calcification | 1 | 2018 | 131 | 0.150 |
Why?
|
| Movement Disorders | 1 | 2017 | 58 | 0.150 |
Why?
|
| Electrodes, Implanted | 1 | 2017 | 98 | 0.140 |
Why?
|
| Deglutition | 1 | 2019 | 221 | 0.140 |
Why?
|
| Endothelium, Vascular | 1 | 2018 | 371 | 0.140 |
Why?
|
| Coma | 1 | 2016 | 17 | 0.140 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2018 | 161 | 0.140 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 951 | 0.140 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2016 | 53 | 0.140 |
Why?
|
| Postoperative Period | 1 | 2016 | 238 | 0.140 |
Why?
|
| Sensitivity and Specificity | 3 | 2020 | 1753 | 0.140 |
Why?
|
| Bupropion | 1 | 2016 | 63 | 0.140 |
Why?
|
| Malformations of Cortical Development | 1 | 2015 | 7 | 0.130 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 396 | 0.130 |
Why?
|
| Muscle Hypotonia | 1 | 2015 | 19 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 627 | 0.130 |
Why?
|
| Drug Overdose | 1 | 2016 | 67 | 0.130 |
Why?
|
| Mental Retardation, X-Linked | 1 | 2015 | 16 | 0.130 |
Why?
|
| Referral and Consultation | 1 | 2017 | 383 | 0.130 |
Why?
|
| Ceramides | 1 | 2019 | 578 | 0.130 |
Why?
|
| Muscular Atrophy | 1 | 2015 | 35 | 0.130 |
Why?
|
| Prospective Studies | 5 | 2022 | 3702 | 0.130 |
Why?
|
| Recurrence | 2 | 2009 | 948 | 0.130 |
Why?
|
| Chi-Square Distribution | 2 | 2007 | 546 | 0.130 |
Why?
|
| Diagnosis, Differential | 4 | 2007 | 1139 | 0.130 |
Why?
|
| Hypertension | 2 | 2021 | 1531 | 0.130 |
Why?
|
| Health Status Disparities | 1 | 2018 | 326 | 0.120 |
Why?
|
| Principal Component Analysis | 3 | 2020 | 55 | 0.120 |
Why?
|
| Child Development | 1 | 2015 | 102 | 0.120 |
Why?
|
| Research Design | 1 | 2018 | 729 | 0.120 |
Why?
|
| Radiography | 3 | 2004 | 572 | 0.120 |
Why?
|
| Intelligence Tests | 1 | 2014 | 32 | 0.120 |
Why?
|
| Cerebrovascular Circulation | 5 | 2020 | 296 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 142 | 0.120 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 426 | 0.120 |
Why?
|
| Visual Fields | 2 | 2019 | 41 | 0.110 |
Why?
|
| Risk Assessment | 2 | 2017 | 2004 | 0.110 |
Why?
|
| Technetium Tc 99m Exametazime | 1 | 2013 | 9 | 0.110 |
Why?
|
| Video Recording | 3 | 2012 | 145 | 0.110 |
Why?
|
| Radionuclide Imaging | 1 | 2013 | 166 | 0.110 |
Why?
|
| Perfusion | 1 | 2013 | 131 | 0.110 |
Why?
|
| Auditory Perceptual Disorders | 1 | 2012 | 4 | 0.110 |
Why?
|
| Family | 1 | 2014 | 293 | 0.100 |
Why?
|
| Databases, Factual | 2 | 2019 | 621 | 0.100 |
Why?
|
| Transcriptome | 1 | 2012 | 164 | 0.100 |
Why?
|
| Pilot Projects | 3 | 2019 | 1341 | 0.090 |
Why?
|
| Oxygen | 5 | 2012 | 386 | 0.090 |
Why?
|
| Functional Neuroimaging | 2 | 2020 | 82 | 0.090 |
Why?
|
| Afferent Pathways | 1 | 2010 | 31 | 0.090 |
Why?
|
| Hand | 2 | 2022 | 90 | 0.090 |
Why?
|
| Martial Arts | 1 | 2009 | 4 | 0.090 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2011 | 134 | 0.090 |
Why?
|
| Hemorrhage | 1 | 2011 | 328 | 0.080 |
Why?
|
| Acute Disease | 3 | 2019 | 658 | 0.080 |
Why?
|
| Motor Activity | 2 | 2009 | 621 | 0.080 |
Why?
|
| Lipreading | 1 | 2008 | 4 | 0.080 |
Why?
|
| Statistics as Topic | 2 | 2007 | 219 | 0.080 |
Why?
|
| Animals | 4 | 2019 | 20877 | 0.080 |
Why?
|
| DNA Repeat Expansion | 1 | 2007 | 1 | 0.080 |
Why?
|
| Trinucleotide Repeats | 1 | 2007 | 8 | 0.080 |
Why?
|
| Rest | 2 | 2019 | 78 | 0.080 |
Why?
|
| Huntington Disease | 1 | 2007 | 15 | 0.080 |
Why?
|
| Mental Recall | 1 | 2007 | 72 | 0.080 |
Why?
|
| Reaction Time | 1 | 2007 | 170 | 0.070 |
Why?
|
| Monte Carlo Method | 1 | 2007 | 124 | 0.070 |
Why?
|
| Geriatric Assessment | 1 | 2007 | 107 | 0.070 |
Why?
|
| Lupus Vasculitis, Central Nervous System | 1 | 2006 | 14 | 0.070 |
Why?
|
| Tomography, Emission-Computed | 1 | 2006 | 40 | 0.070 |
Why?
|
| Speech Acoustics | 1 | 2006 | 23 | 0.070 |
Why?
|
| Neurocytoma | 1 | 2005 | 3 | 0.070 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 2005 | 3 | 0.070 |
Why?
|
| Extremities | 1 | 2006 | 49 | 0.070 |
Why?
|
| Biomarkers | 2 | 2022 | 1593 | 0.070 |
Why?
|
| Neurologic Examination | 3 | 2017 | 107 | 0.070 |
Why?
|
| Posture | 1 | 2006 | 107 | 0.070 |
Why?
|
| Teaching | 1 | 2007 | 169 | 0.070 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2005 | 24 | 0.070 |
Why?
|
| Neurilemmoma | 1 | 2005 | 26 | 0.070 |
Why?
|
| Brazil | 1 | 2005 | 48 | 0.070 |
Why?
|
| Ganglioglioma | 1 | 2004 | 11 | 0.060 |
Why?
|
| Scorpion Venoms | 1 | 2004 | 4 | 0.060 |
Why?
|
| Lumbar Vertebrae | 1 | 2005 | 112 | 0.060 |
Why?
|
| Carcinoma, Papillary | 1 | 2004 | 35 | 0.060 |
Why?
|
| Scorpions | 1 | 2004 | 9 | 0.060 |
Why?
|
| Coffee | 1 | 2004 | 18 | 0.060 |
Why?
|
| Drinking Behavior | 1 | 2004 | 20 | 0.060 |
Why?
|
| Age Distribution | 1 | 2005 | 319 | 0.060 |
Why?
|
| Pediatrics | 1 | 2007 | 341 | 0.060 |
Why?
|
| Entropy | 1 | 2003 | 16 | 0.060 |
Why?
|
| Cranial Sinuses | 1 | 2003 | 11 | 0.060 |
Why?
|
| Craniotomy | 1 | 2003 | 33 | 0.060 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2003 | 4 | 0.060 |
Why?
|
| Spinal Neoplasms | 1 | 2003 | 14 | 0.060 |
Why?
|
| Cerebellar Neoplasms | 1 | 2003 | 17 | 0.060 |
Why?
|
| Medulloblastoma | 1 | 2003 | 24 | 0.060 |
Why?
|
| Pattern Recognition, Automated | 2 | 2018 | 70 | 0.060 |
Why?
|
| Exercise | 1 | 2009 | 657 | 0.060 |
Why?
|
| Image Enhancement | 1 | 2003 | 143 | 0.050 |
Why?
|
| Immunoglobulin E | 1 | 2022 | 91 | 0.050 |
Why?
|
| Dihydroxyphenylalanine | 1 | 2022 | 13 | 0.050 |
Why?
|
| Placebo Effect | 1 | 2021 | 20 | 0.050 |
Why?
|
| Calcinosis | 1 | 2003 | 241 | 0.050 |
Why?
|
| Red Nucleus | 1 | 2021 | 3 | 0.050 |
Why?
|
| Central Nervous System Stimulants | 1 | 2004 | 221 | 0.050 |
Why?
|
| Comorbidity | 2 | 2016 | 1425 | 0.050 |
Why?
|
| Switzerland | 1 | 2021 | 4 | 0.050 |
Why?
|
| Globus Pallidus | 1 | 2022 | 64 | 0.050 |
Why?
|
| Austria | 1 | 2021 | 17 | 0.050 |
Why?
|
| Italy | 1 | 2021 | 36 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2021 | 186 | 0.050 |
Why?
|
| Movement | 2 | 2016 | 179 | 0.050 |
Why?
|
| Craniopharyngioma | 1 | 2000 | 7 | 0.050 |
Why?
|
| Scalp | 1 | 2021 | 47 | 0.050 |
Why?
|
| Gait | 1 | 2022 | 119 | 0.050 |
Why?
|
| Multimodal Imaging | 1 | 2020 | 62 | 0.050 |
Why?
|
| Pathologists | 1 | 2020 | 10 | 0.050 |
Why?
|
| Electrodes | 1 | 2021 | 147 | 0.050 |
Why?
|
| Carotid Artery Thrombosis | 1 | 2000 | 7 | 0.050 |
Why?
|
| Decompression, Surgical | 1 | 2000 | 55 | 0.050 |
Why?
|
| Palate, Soft | 1 | 2000 | 12 | 0.050 |
Why?
|
| Verbal Learning | 1 | 2020 | 29 | 0.050 |
Why?
|
| Pituitary Neoplasms | 1 | 2000 | 52 | 0.050 |
Why?
|
| Lower Extremity | 1 | 2021 | 153 | 0.050 |
Why?
|
| Age Factors | 1 | 2005 | 1860 | 0.050 |
Why?
|
| Medicare | 1 | 2022 | 316 | 0.050 |
Why?
|
| Psychosurgery | 1 | 2019 | 9 | 0.050 |
Why?
|
| Evoked Potentials, Visual | 1 | 2019 | 18 | 0.050 |
Why?
|
| Observational Studies as Topic | 1 | 2019 | 39 | 0.040 |
Why?
|
| Forecasting | 1 | 2021 | 277 | 0.040 |
Why?
|
| Gene Expression | 1 | 2022 | 770 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2020 | 238 | 0.040 |
Why?
|
| Carotid Artery, Internal | 1 | 2000 | 85 | 0.040 |
Why?
|
| Time Factors | 3 | 2019 | 4655 | 0.040 |
Why?
|
| United Kingdom | 1 | 2019 | 152 | 0.040 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2019 | 59 | 0.040 |
Why?
|
| Educational Status | 1 | 2020 | 273 | 0.040 |
Why?
|
| Dopamine | 1 | 2022 | 474 | 0.040 |
Why?
|
| Discriminant Analysis | 1 | 2019 | 36 | 0.040 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2000 | 105 | 0.040 |
Why?
|
| Arm | 1 | 2019 | 59 | 0.040 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 1999 | 83 | 0.040 |
Why?
|
| Wrist | 1 | 2019 | 24 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2019 | 172 | 0.040 |
Why?
|
| Neurologists | 1 | 2018 | 15 | 0.040 |
Why?
|
| Hospitals, Private | 1 | 2018 | 15 | 0.040 |
Why?
|
| Vibration | 1 | 2019 | 32 | 0.040 |
Why?
|
| Physical Stimulation | 1 | 2019 | 67 | 0.040 |
Why?
|
| Hypercholesterolemia | 1 | 2019 | 86 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2019 | 381 | 0.040 |
Why?
|
| Electromyography | 1 | 2019 | 184 | 0.040 |
Why?
|
| Dyslipidemias | 1 | 2019 | 98 | 0.040 |
Why?
|
| Cerebrum | 1 | 2018 | 20 | 0.040 |
Why?
|
| Incidence | 1 | 2022 | 1582 | 0.040 |
Why?
|
| Larynx | 1 | 2018 | 49 | 0.040 |
Why?
|
| Lysophospholipids | 1 | 2019 | 209 | 0.040 |
Why?
|
| United States | 2 | 2022 | 7335 | 0.040 |
Why?
|
| Observer Variation | 1 | 2018 | 330 | 0.040 |
Why?
|
| Pharynx | 1 | 2018 | 89 | 0.040 |
Why?
|
| Goals | 1 | 2018 | 65 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 929 | 0.040 |
Why?
|
| Sphingosine | 1 | 2019 | 315 | 0.040 |
Why?
|
| Prevalence | 1 | 2021 | 1609 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2023 | 2453 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2019 | 294 | 0.040 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 1174 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2007 | 306 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 281 | 0.040 |
Why?
|
| Dystonia | 1 | 2015 | 18 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2021 | 1447 | 0.030 |
Why?
|
| Reading | 1 | 2015 | 19 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2019 | 1692 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2017 | 298 | 0.030 |
Why?
|
| Depression | 1 | 2022 | 942 | 0.030 |
Why?
|
| Adolescent Development | 1 | 2015 | 28 | 0.030 |
Why?
|
| South Carolina | 1 | 2022 | 2750 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2018 | 310 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 693 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 2790 | 0.030 |
Why?
|
| Iceland | 1 | 2012 | 2 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2016 | 621 | 0.030 |
Why?
|
| Phenotype | 1 | 2015 | 946 | 0.030 |
Why?
|
| Spin Labels | 1 | 2011 | 27 | 0.020 |
Why?
|
| Middle Cerebral Artery | 1 | 2011 | 57 | 0.020 |
Why?
|
| Psychophysics | 1 | 2010 | 30 | 0.020 |
Why?
|
| Putamen | 1 | 2010 | 35 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2012 | 954 | 0.020 |
Why?
|
| Names | 1 | 2009 | 4 | 0.020 |
Why?
|
| Astrocytes | 1 | 2012 | 270 | 0.020 |
Why?
|
| Gyrus Cinguli | 1 | 2010 | 113 | 0.020 |
Why?
|
| Face | 1 | 2009 | 46 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 1419 | 0.020 |
Why?
|
| Mice | 1 | 2019 | 8472 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2007 | 95 | 0.020 |
Why?
|
| Intracranial Hemorrhages | 1 | 2007 | 80 | 0.020 |
Why?
|
| Saccades | 1 | 2006 | 17 | 0.020 |
Why?
|
| Eye Movements | 1 | 2006 | 44 | 0.020 |
Why?
|
| Oculomotor Muscles | 1 | 2006 | 54 | 0.020 |
Why?
|
| Laminectomy | 1 | 2005 | 13 | 0.020 |
Why?
|
| Inflammation | 1 | 2012 | 1030 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2005 | 351 | 0.020 |
Why?
|
| Cues | 1 | 2010 | 654 | 0.020 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2005 | 137 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2006 | 186 | 0.020 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2003 | 7 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2003 | 164 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2004 | 453 | 0.010 |
Why?
|
| Quadriplegia | 1 | 2000 | 29 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 1745 | 0.010 |
Why?
|